CareDx, Inc. CDNA

CDNA Company Overview

CareDx, Inc. is a precision diagnostics company focused on improving outcomes for organ transplant patients. The company operates primarily in the molecular diagnostics and transplant healthcare industries, providing testing solutions that help clinicians monitor organ transplant rejection, assess patient risk, and manage long-term transplant care. CareDx’s business is centered on post-transplant patient management rather than therapeutic drugs or devices.

The company’s primary revenue drivers are its diagnostic testing services, most notably the AlloSure and AlloMap tests, which are used to monitor organ transplant rejection through non-invasive methods. CareDx primarily serves transplant centers, hospitals, and clinicians, with a strong concentration in heart and kidney transplant markets. Founded in 1998, CareDx evolved from an early-stage diagnostics company into a specialized transplant-focused platform through internal test development and strategic acquisitions that expanded its testing portfolio and data capabilities.